Lars‑Peter Rudolf
Senior Attorney
Lars-Peter Rudolf’s practice focuses on European and German competition law.
Lars joined the firm in 2002 and became a senior attorney in 2008. He was resident in the Frankfurt office from 2002 to the beginning of 2004, and he was resident for one year in the Cologne office before joining the Brussels office in 2005.
Lars has also obtained a diploma in biochemistry and the first state examination in medicine, both in Berlin.
Notable Experience
ExxonMobil in securing a €20 million fine reduction before the EU General Court in connection with the paraffin wax cartel.
GlaxoSmithKline on the global antitrust aspects of its game-changing, multibillion-euro, three-part transaction with Novartis involving its consumer health care, vaccines and oncology businesses.
Google with regard to a complaint by the German newspaper and magazine publishers’ association to the German Federal Cartel Office.
NSK in a EU cartel settlement concerning bearings and in follow-on damages claims.
Publications
- Co-author of, “German Court Confirms Narrow Scope of Transaction Value Threshold in Merger Control,” Cleary Antitrust Watch blog, March 3, 2025.
- Author of, “Austria Asphalt: Only Full-function Joint Ventures Subject to Review Under the EUMR,” Journal of European Competition Law & Practice, February 2018, Vol. 9, No. 2, pp. 107-109.
- Co-author of a textbook on Regulation (EC) No 1/2003 implementing the rules on competition laid down in Articles 101 and 102 of TFEU.
- Co-author of an article on standardization and competition law, “Die ‘Unbedingtheit’ eines Lizenzangebotes als Voraussetzung des kartellrechtlichen Zwangslizenzeinwands im patentrechtlichen Unterlassungsverfahren.”
- Author of, “Joint Ventures—The Relevance of the Full Functionality Criterion Under the EU Merger Regulation: There Remains a Need for Clarification,” Journal of European Competition Law & Practice, May 9, 2012.